Evidence map›Paper›PMID 40098966›Full record

ArticleFrontiers in immunology2025

Gut microbiota and other factors associated with increased T cell regulation in HIV-exposed uninfected infants.

Michael J Johnson, Sarah K Lazarus, Ashlynn E Bennett, Adriana Tovar-Salazar, Charles E Robertson, Jennifer M Kofonow, Shaobing Li, Bruce McCollister, Marta C Nunes, Shabir A Madhi and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Michael J JohnsonDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Sarah K LazarusDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Ashlynn E BennettDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Adriana Tovar-SalazarDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Charles E RobertsonDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Jennifer M KofonowDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Shaobing LiDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Bruce McCollisterDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Marta C NunesSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit and Department of Science and Technology/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Shabir A MadhiSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit and Department of Science and Technology/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Daniel N FrankDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Adriana WeinbergDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Funding

Developing Interventions for Protecting HIV-Exposed Uninfected Infants against Severe InfectionsR01HD116631 · NICHD · UNIVERSITY OF COLORADO DENVER · PI Shabir A Madhi, ADRIANA WEINBERG · 2024 to 2026
$2.3M
Tregs, Gut Microbiome and Immune Responses in HIV-Exposed and Unexposed InfantsU01AI131360 · NIAID · UNIVERSITY OF COLORADO DENVER · PI MADHI, SHABIR A, WEINBERG, ADRIANA · 2017 to 2021
$2.2M
Relationship between maternal and fetal immune responsesR01HD107793 · NICHD · UNIVERSITY OF COLORADO DENVER · PI WEINBERG, ADRIANA · 2022 to 2024
$1.5M
NIAID NIH HHS U01 AI131360NICHD NIH HHS R01 HD107793NICHD NIH HHS R01 HD116631
6 · The paper itself

Abstract

Introduction: Infants exposed to HIV and uninfected (HEUs) are at higher risk of infectious morbidity than HIV-unexposed uninfected infants (HUUs). Multiple immune defects of unknown origin were observed in HEUs. We hypothesized that HEUs have more regulatory and inhibitory checkpoint-expressing T cells (Treg, Tici) than HUUs, which may dampen their immune defenses against pathogens. Method: We used flow cytometry to measure 25 Treg/Tici subsets in HEUs and HUUs at birth, 6, 28, and 62 weeks of life. We used maternal and infant gut microbiome data reported in a previous study to establish correlations with the Treg/Tici. Results: At birth, 3 Treg subsets, including the prototypic CD4+FOXP3+ and CD4+FOXP3+CD25+, had higher frequencies in 123 HEUs than in 117 HUUs, and 3 subsets had higher frequencies in HUUs. At 28 and 62 weeks of age, 5 Treg/Tici subsets had higher proportions in HEUs than HUUs. The frequencies of the Treg/Tici subsets that diverged between HEUs and HUUs at birth correlated with differential relative abundances of bacterial taxa in the maternal gut microbiome. The Treg/Tici subsets with significantly different frequencies at subsequent visits correlated with the concurrent composition of the infant gut microbiome. In vitro, treatment of HUU peripheral blood mononuclear cells (PBMC) with bacterial taxa most abundant in HEUs expanded Treg/Tici subsets with higher frequencies in HEUs than HUUs, recapitulating the in vivo correlations. Conversely, in vitro treatment of HEU PBMC did not increase Treg/Tici frequencies. Other factors that correlated with increased Treg/Tici frequencies were low maternal CD4+ T cells in HEUs at birth and male sex in the HUUs at 28 weeks of life. Discussion: This study shows that maternal and infant gut dysbiosis are central to the increase in Treg/Tici in HEUs and may be targeted by mitigating interventions.

Indexed as

Gastrointestinal MicrobiomeHIV InfectionsT-Lymphocytes, RegulatoryAdultFemaleHumansInfantInfant, NewbornMalePregnancyBlautia wexleraeaEnterobacter cloacaegut microbiomeHIV-exposed uninfected infantshuman immunodeficiency virusKlebsiella pneumoniaeregulatory T cellsRuminococcus bromii

Identifiers

PMID40098966
PMCPMC11911520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.